Cure My Disease

Don't miss your cure!

 Log in / Sign up

New device aims to make pancreatic and bile duct procedures safer

NCT ID NCT07696572

Disease control Sponsor: Orlando Health, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tracks up to 30 adults who need an endoscopic ultrasound (EUS) procedure using a new device called RIVOS. The device helps doctors access and treat problems like fluid collections, blockages, or chronic pancreatitis. Researchers will measure how often the procedure works and check for any side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RIVOS™ EUS access device
What this could lead to
If successful, this device could offer a safer, more effective way to drain fluid collections or relieve blockages in the pancreas and bile ducts without major surgery.
What could go wrong
This is a small, early registry study with only 30 patients, so results may not apply to everyone. There is a risk of procedure-related complications such as bleeding, infection, or device failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients undergoing EUS-guided interventions

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * All patients undergoing EUS-guided interventions using the RIVOS™ EUS access device Exclusion Criteria: * Age \< 18 years * Patients who did not undergo EUS-guided interventions using the RIVOS™ EUS access device

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biliary obstruction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholestasis chronic pancreatitis malignant pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Biliary obstruction Chronic pancreatitis Pancreatic cancer non-resectable Pancreatic duct obstruction Pancreatic fluid collections

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Orlando Health Digestive Health Institute

    RECRUITING

    Orlando, Florida, 32806, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.